Cytokinetics, Incorporated
CYTK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$306,178 | -$134,370 | -$161,376 | -$150,020 |
| Dep. & Amort. | $2,679 | $2,285 | $2,300 | $2,383 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $30,696 | $27,535 | $23,549 | $0 |
| Change in WC | $22,531 | -$51,111 | -$5,203 | $41,714 |
| Other Non-Cash | $142,767 | $27,425 | $9,113 | $40,353 |
| Operating Cash Flow | -$107,505 | -$128,236 | -$131,617 | -$65,570 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9,354 | -$4,145 | -$5,664 | -$1,290 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$335,452 | -$217,966 | -$164,105 | -$121,125 |
| Inv. Sales/Matur. | $273,827 | $279,992 | $275,725 | $233,278 |
| Other Inv. Act. | $0 | -$5,000 | $0 | $0 |
| Investing Cash Flow | -$70,979 | $52,881 | $105,956 | $110,863 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $324,251 | -$2,698 | -$2,884 | -$2,914 |
| Stock Issued | -$14,396 | $6,745 | $7,651 | $6,480 |
| Stock Repurch. | $21,331 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$720 | $74,486 | -$13 | -$1,182 |
| Financing Cash Flow | $330,466 | $78,533 | $4,754 | $2,384 |
| Forex Effect | $46 | -$682 | -$270 | $292 |
| Net Chg. in Cash | $152,028 | $2,496 | -$21,177 | $47,969 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $76,551 | $74,055 | $95,232 | $47,263 |
| End Cash | $228,579 | $76,551 | $74,055 | $95,232 |
| Free Cash Flow | -$116,859 | -$132,381 | -$137,281 | -$66,860 |